A new systematic literature review adds complexity to the controversy over testosterone’s relationship to risk for myocardial infarction, stroke, cardiovascular death, and all-cause mortality. Last year, the TRAVERSE (Testosterone Replacement Therapy for Assessment of Long-term Vascular Events and Efficacy ResponSE in Hypogonadal Men) trial was the first randomized, placebo-controlled study designed and powered to determine...
Category: <span>Pharmaceutical Updates</span>
Post
Researchers develop theory on traveling waves of activity in the human brain
by Katharina Kalhoff and Ole Kamm, Berlin Institute of Health in der Charité Credit: Brain Simulation Section, BIH, Charité – Universitätsmedizin Berlin For the first time, researchers led by Professor Dr. Petra Ritter’s team have succeeded in explaining the propagation of traveling waves of activity in the human brain using a computer simulation. Previous studies...
Post
Patient “chronotype” could impact best time to take blood pressure medication.
NEWS RELEASE 16-MAY-2024 Peer-Reviewed PublicationUNIVERSITY OF DUNDEE DR FILIPPO PIGAZZANI, FROM THE UNIVERSITY OF DUNDEE SCHOOL OF MEDICINE. CREDIT: UNIVERSITY OF DUNDEE Research conducted by the University’s School of Medicine, in collaboration with Helmholtz Munich, and in partnership with an international team of researchers from Italy, UK and the USA, has revealed that a person’s...
Post
A second chance for new antibiotic agent
Biochemistry NEWS RELEASE 16-MAY-2024 Peer-Reviewed PublicationRUHR-UNIVERSITY BOCHUM MORE AND MORE BACTERIA ARE DEVELOPING RESISTANCE TO ANTIBIOTICS. RESEARCHERS ARE THEREFORE LOOKING FOR ALTERNATIVE ACTIVE INGREDIENTS. CREDIT: © RUB, MARQUARD Significant attempts 20 years ago The study focused on the protein peptide deformylase (PDF). Involved in protein maturation processes in cells, PDF is essential for the survival...
Post
Weight Loss Drug Tested in Mice May Be More Effective Than Existing Medicines
Promising new therapy for obesity that leads to greater weight loss in mice than existing medications. NewsPublished: May 17, 2024 | Original story from the University of Copenhagen Credit: Diana Polekhina / Unsplash. “I consider the drugs available on the marked today as the first generation of weight-loss drugs. Now we have developed a new...
Post
Antioxidant Dietary Supplement “Twendee X®” can help counter systemic sclerosis
NEWS RELEASE 17-MAY-2024 Study finds the supplement effective in inhibiting fibrosis and suppressing disease activity and progression of systemic sclerosis, an intractable disease Peer-Reviewed PublicationLOUIS PASTEUR CENTER FOR MEDICAL RESEARCH OXIDATIVE STRESS IS KNOWN TO EXACERBATE FIBROSIS AND AUTOIMMUNITY. IN A NEW STUDY, RESEARCHERS FROM JAPAN HAVE INVESTIGATED THE EFFECTS OF A DIETARY ANTIOXIDANT SUPPLEMENT...
Post
Body’s ‘message in a bottle’ delivers targeted cancer treatment – pharmaceutical
by Karolinska Institutet Engineering cells to produce EVs decorated with an antibody-binding moiety specific for the Fc domain. Credit: Nature Biomedical Engineering (2024). DOI: 10.1038/s41551-024-01214-6Researchers at Karolinska Institutet in Sweden have succeeded in delivering targeted cancer treatment via small membrane bubbles that our cells use to communicate. A study, “Antibody-displaying extracellular vesicles for targeted cancer...
Post
First Test of Drug in a Patient with Life-Threatening Blood Clotting Disorder – pharmaceutical
Results from this first use of the drug for this condition warrants testing the drug in a clinical trial.News Published: May 20, 2024 | Original story from Massachusetts General Hospital Read time: 2 minutesA team led by investigators from Massachusetts General Hospital, a founding member of the Mass General Brigham healthcare system, used a new...
Post
Diet and Exercise in a Pill Are Real: How Mimetics Work – pharmaceutical
If couch-potato lab mice had beach-body dreams and if they could speak, they might tell you they’re thrilled by advances in the science of exercise and calorie-restriction (CR) mimetics. In recent studies conducted at research centers across the United States, mice have chowed down, fattened up, exercised only if they felt like it, and still...
Post
Anti-diabetic treatment associated with reduced risk of developing blood cancer
by American Society of Hematology MAY 17, 2024 Metformin 500mg tablets. Credit: public domainPeople who use metformin are less likely to develop a myeloproliferative neoplasm (MPN) over time, indicating that the treatment may help prevent the development of certain types of cancers, according to a study published in Blood Advances. Metformin is a therapy used...